But antitrust experts say it's only possible for the Department of Justice to block the merger. DOJ approved the $70 billion deal in October. Meanwhile, CVS and Aetna are moving ahead with integration plans. Other industry news looks at CVS' new prescription drug-price plans and rising costs of Pitocin and Ketamine.

from Kaiser Health News https://ift.tt/2E3rPTK

Related Posts:

0 comments:

Post a Comment

Popular Posts